Exane BNP Paribas Initiates Coverage On Dynatrace with Neutral Rating, Announces Price Target of $52
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas has initiated coverage on Dynatrace with a Neutral rating and set a price target of $52.
October 08, 2024 | 5:33 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Exane BNP Paribas has initiated coverage on Dynatrace with a Neutral rating and a price target of $52, suggesting limited short-term upside.
The Neutral rating suggests that Exane BNP Paribas does not expect significant short-term movement in Dynatrace's stock price. The price target of $52 is close to the current trading price, indicating limited upside potential. This analysis is important for investors considering the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100